Oxford Cannabinoid submits trials application for agonist

(marketscreener.com) Oxford Cannabinoid Technologies Holdings PLC - cannabinoid medicines-focused pharmaceutical firm - Says that on Wednesday, it submitted a combined clinical trials application to the UK Medicines & Healthcare products Regulatory Agency and the Wales Research Ethics Committee 2 for its lead programme OCT461201.OCT461201 "is a selective...https://www.marketscreener.com/quote/stock/OXFORD-CANNABINOID-TECHNO-123042923/news/Oxford-Cannabinoid-submits-trials-application-for-agonist-42665166/?utm_medium=RSS&utm_content=20230105